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ABSTRACT
The interpretation of sampling data plays a crucial role in policy response to the spread of a disease during an epidemic, such
as the COVID-19 epidemic of 2020. However, this is a non-trivial endeavor due to the complexity of real world conditions and
limits to the availability of diagnostic tests, which necessitate a bias in testing favoring symptomatic individuals. A thorough
understanding of sampling confidence and bias is necessary in order make accurate conclusions. In this manuscript, we
provide a stochastic model of sampling for assessing confidence in disease metrics such as trend detection, peak detection,
and disease spread estimation. Our model simulates testing for a disease in an epidemic with known dynamics, allowing
us to use Monte-Carlo sampling to assess metric confidence. We use this method to show that trends in the disease may
be identified using under 10000 biased samples each day, and an estimate of disease spread can be made with additional
1000−2000 unbiased samples each day. We also demonstrate that the model can be used to assess more advanced metrics
by finding the precision and recall of a strategy for finding peaks in the dynamics.
INTRODUCTION
Policy decisions in the face of an epidemic rely on perceptions of the population dynamics of an infectious disease, for example
whether cases are growing or shrinking. If everyone were tested every day, then this would be a matter of looking at the trend in
the total number of positive tests per day. However, this scenario is unrealistic. In actuality, the population sampling needed
to track an epidemic in a community will depend on the nature of the question we would like to answer. Sometimes, these
questions are in conflict with each other. For instances, the primary goal of healthcare providers is to identify infected patients
in the hospital or clinical setting so that appropriate treatment and protective measures may be prescribed, while at the other
extreme the epidemiologist concerned with infection prevention within the population may be interested in determining the
number of infected individuals in the population in order to focus efforts at limiting disease spread. Clearly, the former is
very targeted towards patients showing up at a clinic with certain symptoms while the latter requires broad testing of both
symptomatic and asymptomatic populations.
The reality is that testing needs to serve multiple purposes with a finite number of tests. In particular, the COVID-19
pandemic and response from world leaders has shed light on the need for a better understanding of community infection data
and how to use it, both for decision making and media reporting. Some of the particular challenges are the significant proportion
of asymptomatic carriers of the disease Bai et al. (2020); Mizumoto et al. (2020) and the changing availability of the testing.
Both have resulted in testing that is strongly biased towards infected individuals and not representative of the proportion of
cases in the population. Here, we focus on two intermediate use cases — individuals and businesses that need to estimate risk,
i.e., the probability that an infected person will be present in a given situation, and public policy makers that need to understand
changing trends in the spread of the disease. We show that this can be done with a combination of biased and unbiased sampling
that requires many fewer tests to be performed every day, but importantly must include the number of negative tests in addition
to the number of positive cases that is more widely reported. Notably, this is in line with the World Health Organization’s global
surveillance guidelines, which include reporting of total tests so positive percentage can be determined Organization (2020).
The purpose of this manuscript is to introduce a method for assessing confidence in conclusions made from biased sampling
of the spread of an epidemic. We begin with a calculation of the number of tests needed to identify a significant portion of
infected individuals in a given day. We then describe a stochastic dynamical model that simulates testing over the course of
an epidemic with known dynamics. We then show how we can use a given model of epidemic dynamics to investigate the
amount of testing needed to estimate disease spread and trends in disease. We further use our approach to simulate testing with
variable bias and error and investigate the roles of bias and error in testing. We find that amount of testing needed to identify
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most infected people in a population of 300 million (approximately the population of the United States), is extremely high. On
the other hand, we show that trends in the spread of the disease can be accurately identified by sign with less than 10000 biased
tests per day. We show that approximately 1000 additional unbiased tests can be used to estimate the bias in testing. This can
be used to estimate the extent of disease spread in the community on a daily basis. Our approach can also be used to assess the
reliability of many data analysis techniques. We demonstrate this by assessing a strategy for finding peaks in the dynamics of
the outbreak by using a smoothed numerical derivative of the data. Finally, we show the importance of understanding bias
under the conditions of limited testing by examining COVID-19 data from within the United States of America.
As a special note, we emphasize that while many important efforts are being made to model the spread of COVID-19 and
determine how testing can be used to reduce that spread Reich et al. (2020); Piguillem and Shi (2020); Alvarez et al. (2020);
Chowdhury et al. (2020), our approach does not attempt to predict disease spread. Instead, we are testing confidence in data
analysis sampled from known dynamics. In other words, rather than trying to predict the future, our work focuses on estimating
confidence in current trends under non-ideal conditions.
METHODS
Sampling all infected
Sampling the population in order to identify all or some large proportion of the infected individuals will require a large amount
of testing. If we assume that testing is done in a single day, the proportion of infected in the population is roughly constant
in that day, and no person is tested more than once, the number of positive cases will follow a hypergeometric distribution
based on the number of cases in the population, the bias in the testing, and the number of tests performed. We can compute the
cumulative distribution function of this distribution, and so compute the number of tests needed so that the probability that
some number of cases are found.
Precisely, we use the hypergeometric distribution with population rBT +(1− r)T and infected rBT , where B is the same
biased used in our sampling model below, r is the proportion of the population that is infected, and T is the total population size.
A stochastic model for disease sampling.
Initial model.
We developed a stochastic model to simulate the sampling of a population which is undergoing an epidemic with known
dynamics. That is, given an underlying set of dynamics tracking asymptomatic infected individuals, symptomatic infected
individuals, and non-infected individuals, we simulate testing members of this population for the disease. Let I1(t), I2(t),
and H(t) represent the number of asymptomatic infected individuals, symptomatic infected individuals, and non-infected
individuals in the population, respectively, for t ∈ [0,T ].
Tests are assumed to be carried out according to a Poisson point process with (possibly time varying) intensity function
λ (t). The intensity function λ (t) can be interpreted as the rate at which members of the population are tested for the diseased,
and so an increase in test availability, for example, would be reflected in this model with an increase in λ (t).
Each time a test is performed, we determine the status of the person tested. Under the assumption of unbiased testing,
we categorize a person into one of three pools. The probability of a test result deponds on the respective proportion of the
population which belongs to each pool. That is, the probability the test is performed on an asymptomatic infected person is
P(this testee is asymptomatic infected) =
I1(t)
I1(t)+ I2(t)+H(t)
(1)
Likewise,
P(this testee is symptomatic infected) =
I2(t)
I1(t)+ I2(t)+H(t)
(2)
and
P(this testee is non-infected) =
H(t)
I1(t)+ I2(t)+H(t)
. (3)
We also account for the possibility that a test may give a false-positive or false-negative with some constant probability. Let
ε1 ∈ [0,1] be the false-negative probability of the test, and ε2 ∈ [0,1] be the false-postive probability. Then, for any given test
we can combine eqs. (1) to (3) to see the following:
P(positive test) = (1− ε1)P(person is infected)+ ε2P(person is not infected) (4)
and
P(negative test) = ε1P(person is infected)+(1− ε2)P(person is not infected) (5)
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Accounting for testing bias.
Testing for disease in a population is not done uniformly at random. Instead, an individual displaying symptoms of the disease
is much more likely to be tested for it than one who is not. We may model a bias in testing by adjusting eqs. (1) to (3). Let B(t)
be some function of time, with B(t)≥ 1 for all t ∈ [0,T ]. Then, we can reflect the bias of the testing procedure by re-weighting
the population for each test performed. We replace eqs. (1) to (3) with the following:
P(this testee is asymptomatic infected) =
I1(t)
I1(t)+B(t)I2(t)+H(t)
(6)
P(this testee is symptomatic infected) =
B(t)I2(t)
I1(t)+B(t)I2(t)+H(t)
(7)
P(this testee is non-infected) =
H(t)
I1(t)+B(t)I2(t)+H(t)
(8)
and combine eqs. (6) to (8) with eqs. (4) and (5) to determine the probability of a single test result. The result is that the number
of positive and negative tests that have been carried out up to time t are each non-homogeneous Poisson point processes with
intensity functions
λ+(t) = λ (t)
[
(1− ε1)
(
I1(t)
I1(t)+B(t)I2(t)+H(t)
+
B(t)I2(t)
I1(t)+ I2(t)+H(t)
)
+ε2
(
H(t)
I1(t)+B(t)I2(t)+H(t)
)]
(9)
λ−(t) = λ (t)
[
ε1
(
I1(t)
I1(t)+B(t)I2(t)+H(t)
+
B(t)I2(t)
I1(t)+B(t)I2(t)+H(t)
)
+(1− ε2)
(
H(t)
I1(t)+B(t)I2(t)+H(t)
)]
. (10)
respectively.
We note that the model described above essentially assumes an infinite total population size. Practically, this means that
testing is done on an insignificant proportion of the population, or equivalently that members of a population are immediately
eligible to be re-tested after being tested. In appendix B, we describe a modification for this model which accounts for small
population size and non-immediate retesting.
Simulation with Gillespie’s Algorithm
Both the initial model described in this manuscript and the model adjusted for small populations can be written as the sum of
Poisson point processes with time-varying intensities. They can therefore be simulated using a slight adjustment to Gillespie’s
Algorithm (also called the Stochastic Simulation Algorithm)(Gillespie, 1976, 1977). This adjustment accounts for possible
changes in the intensity functions between points in the Poisson processes, for example from variations in λ (t) or B(t). This
adjustment is made by choosing event times according to the maximum values of any time-varying functions, and allowing for
the possibility of a non-event at each event time, a procedure often called thinning (Asmussen and Glynn, 2007; Anderson and
Yuan, 2019).
Simulation of the models as described allow us to perform Monte-Carlo estimations of the confidence that can be assumed
in the calculation of various statistics from data. We perform Monte-Carlo estimation by repeatedly simulating sampling over
the course of an epidemic with given dynamics and determining the success rate or average error of in determining a metric
from simulated sampling when compared to determining the same metric from the known underlying dynamics.
Estimating trends in disease spread.
To assess trends in data simulated according to our model, we discretize the time interval [0,T ] into evenly spaced intervals
(e.g. into single day increments) ending at times t1, t2, ..., tN = T . We then compute positive-test proportions for these intervals,
simply defined as the proportion of tests carried out within the interval that were positive. This allows us to make sense of the
simulated data even as testing capacity λ (t) varies in time.
We estimate N-day trends in disease spread using a linear least-squares fit to N consecutive days of simulated positive test
proportions. We define the linear trend of the simulated data to be the slope of this fitted line. This can then be compared to a
linear fit to the infected proportion
I1(t)+ I2(t)
I1(t)+ I2(t)+H(t)
over the same time interval, computed using time-discretized dynamics.
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Figure 1. Number of samples needed to identify 90% of infected individuals with 90% confidence, computed using a
hypergeometric distribution.
Finding peaks in disease spread.
We attempt to find peaks in the data by estimating the time derivative of the positive-test proportions simulated. We then identify
peaks as points at which the derivative crosses from positive to negative. That is, we estimate the change in true positive-test
proportion from day to day, and identify when this proportion stopped increasing and began to decrease.
To estimate the time derivative of positive proportions, we first compute a numerical derivative over each time interval. We
then blur this discretized derivative to reduce noise (and therefore false peaks) using a one-dimensional Gaussian filter.
Underlying dynamics
Our model is designed to simulate sampling of an epidemic with any non-negative underlying compartmental dynamics. This
means that the number of healthy, symptomatic infected, and asymptomatic infected members of a population can be any
non-negative known functions of time. As a consequence of this feature, some set of known dynamics must be either chosen
directly or generated by another dynamic model. Confidence in metric sampling is then measured against the known dynamics.
To demonstrate our method, we use the SIR model (Edelstein-Keshet, 2005; Hethcote, 2000; Kermack and McKendrick,
1927) with a time-variable rate of disease spread to generate underlying dynamics, as well as a similar compartmental model
that allows for asymptomatic individuals, which we refer to as the SAIR model. See appendix A for details. These models
represent a popular, simple choice of dynamic epidemic model with parameters often reported by the lay news media.
RESULTS
Sampling all infected
One obviously crucial role of testing of a disease outbreak is to identify patients for treatment and possibly quarantine. From
that perspective, it is crucial to identify all or most infected members of a community. We therefore assess the number of tests
this would require. Using the cumulative distribution function of the hypergeometric distribution, we see that in a community
of 300 million with 5% infection, we need approximately 27,009,300 unbiased tests to have 90% confidence that we have
found 90% of the cases. For higher bias, fewer tests are needed, as seen in fig. 1.
Simulated sampling
We simulated sampling as described above with underlying dynamics generated by ODE models of outbreaks. We use the
positive test proportion per day as our sampled variable, in order to account for variations in testing capacity. Figure 2
demonstrates that day-to-day variations in testing capacity are reflected in positive test count but not proportion, and that only
recording positive test count may mask the real dynamics.
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Figure 2. Positive proportion of tests and scaled positive tests per day. Testing capacity is initially 1350 tests per day but rises
to 2700 midway through the simulation.
Biases in testing
Biased sampling
With false positive and false negative rates equal to 0, biased sampling causes an overestimation in the proportion of a large
population that is infected. If tests are taken at random in the population (and so not biased), the proportion of positive tests will
on average be the same as the proportion of infected individuals r(t), which is the sum of the proportions of symptomatic and
asymptomatic infected individuals:
r(t) =
I1(t)+ I2(t)
I1(t)+ I2(t)+H(t)
=
I1(t)
I1(t)+ I2(t)+H(t)
+
I2(t)
I1(t)+ I2(t)+H(t)
= rI1(t)+ rI2(t). (11)
Biasing the tests towards symptomatic individuals is analogous to sampling a population with extra symptomatic individuals
added:
rB(t) =
BrI1 + rI2
1+(B−1)rI1
> r(t) (12)
and we note that this overestimation will not lessen with a higher number of samples. Including the rate of false positive and
negative tests, this becomes
rB(t) =
BrI1(1− ε1)+ rI2(1− ε1)+ ε2(1− rI1 − rI2)
1+(B−1)rI1
> r(t) (13)
In order to estimate the spread of the disease in a community, we can estimate the bias B if we have unbiased sample data as
well. To do this with only positive/negative test data, we must assume that the ratio of symptomatic to asymptomatic infected
members of the community is constant (i.e. r1 = cr2). For a more accurate daily estimate, we need to reduce the variance in our
estimate of B. We simulated an estimate of B with various biased and unbiased sample capacities. Variances for these estimates
are shown in fig. 3.
Linear Trends
Dependence on dynamic slope
The ability to correctly characterize a linear trend in the dynamics from sampled data depends on the strength of that trend as
well as the sampling of the population. Confidence in trends is reported as the proportion of 5 day intervals in 1000 simulations
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Figure 3. Variance of bias estimate for various sampling capacities. This variance represents the error in estimation from a
single day of biased and unbiased tests. In this experiment, we do not have asymptomatic infected individuals.
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Figure 4. Simulation shows how biasing testing towards symptomatic individuals overestimates infected proportion of the
population, even with no false-positive or false-negative tests, and a high rate of testing. Here, the bias parameter is set to
B(t) = 10 and the testing rate is λ (t) = 8100 for all t.
which correctly identified the sign (positive/negative) of the linear fit to the dynamics. In fig. 5, we test sampling’s ability to
identify a constant trend (i.e. linear increase or decrease) in the infected proportion. We see that sampling identifies the sign of
the trend robustly for large enough absolute slope. We also see that increasing sampling improves identification of trends in
data.
In fig. 6, we show how this dependence on the underlying dynamics effects confidence in trend identification over the
course of a simulated outbreak. Here, we see that trends can be identified with good confidence with 8100 samples per day for
most time-intervals. Those intervals in which trends could not be confidently identified were those that included local maxima
(peaks) or minima (valleys) in the epidemic dynamics.
Confidence with bias and errors
In fig. 7, we see that biased sampling actually improves the confidence of an identified trend. This is due to magnification
of the trend in infections which are relatively rare. Biased testing allowed for better trend confidence in error free (no false
positive/false negative) testing as well as testing with 10% error rate.
Peak Finding
We observe that identification of peaks in data using the smoothing method described above has a high chance of finding the
peaks in the dynamics, but has very poor precision, providing many false peaks. Figure 8 shows the precision and recall of this
peak finding for one set of dynamics and sampling assumptions, while tables 1 and 2 give precision and recall for peak finding
with two sets of dynamics (SIR generated and SAIR generated) with various sampling assumptions (with and without bias and
errors). Tables 1 and 2 were generated with a smoothing parameter of 5, while fig. 8 uses smoothing from 1 to 10, with 10
giving the highest precision and recall.
Trends in COVID-19 data
Using data from The COVID Tracking Project(Lipton et al., 2020) to compute 5-day trends of the outbreak in the state of
Minnesota, shown in fig. 9, with data from March 6 to April 31, 2020.
We also note a significant negative correlation between positive test percentage and number of tests performed in many
states. This can be explained by a reduction in bias as more tests become available (i.e. an increased willingness to test members
of the population not showing symptoms). In fact, a strong negative correlation could indicate that testing may have been
initially used in a more restrictive, and therefore more heavily biased, manner. We hypothesize that as testing increases, testing
bias will approach some limit that represents the preferred policies of healthcare and government organizations. It may be that
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Figure 5. Trend fitting for 5-day interval of dynamics with constant slope. Top: confidence in the sign of the estimated slope
as actual slope varies. Bottom: Error in estimated slope as slope varies.
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Figure 6. Trend sign confidence changes with the underlying dynamics.
Figure 7. Confidence in linear trends identified for sampling of SIR and SAIR dynamics with and without bias and errors.
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Figure 8. Precision and recall for peak finding with various smoothing parameters. These simulations sought peaks in a
course of infection dynamics generated by the SIR model with a variable β (t). The underlying dynamics were the same as
shown in fig. 4. Sampling was done with bias of 10 and false positive/false negative rates of 10%.
Sampling per day
900 2700 8100
BiasedSAIR 0.1541 0.2198 0.2959
BiasedSIR 0.1865 0.3144 0.5210
ExactSAIR 0.1155 0.1924 0.3045
ExactSIR 0.1228 0.2080 0.3651
PerfectSAIR 0.1871 0.2566 0.3386
PerfectSIR 0.2400 0.3924 0.6132
UnbiasedSAIR 0.0827 0.1034 0.1568
UnbiasedSIR 0.0818 0.1101 0.1783
Table 1. Precision of peak finding for various sampling
and dynamics.
Sampling per day
900 2700 8100
BiasedSAIR 0.8955 0.9000 0.8475
BiasedSIR 0.8870 0.9370 0.9740
ExactSAIR 0.8565 0.9135 0.9370
ExactSIR 0.8580 0.9045 0.9575
PerfectSAIR 0.9060 0.8955 0.7990
PerfectSIR 0.8985 0.9570 0.9890
UnbiasedSAIR 0.8195 0.8505 0.8970
UnbiasedSIR 0.8005 0.8545 0.9180
Table 2. Recall of peak finding for various sampling
and dynamics.
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Figure 9. 5-day trend of positive test proportion in the state of Minnesota, using data from The COVID tracking projectLipton
et al. (2020)
even with high testing capacity, some bias will exist due to these policies. Changes in policies will result in future changes in
testing bias. We note that our model can simulate a change in bias with a time-dependent bias parameter B in eqs. (6) to (8).
It is worth noting that some day to day variation may be the result of irregularities in negative test reporting, as evidenced
by days with 100% positive rate. Pearson correlations are shown in fig. 10, with significance computed as p-value of the
correlation coefficient.
DISCUSSION
While the multiple purposes of infectious disease testing would be satisfied if all or almost all infected individuals could be
identified, the amount of testing needing to have a high level confidence that almost all infected individuals have been identified
is prohibitively high. For example, the hypergeometric distribution suggest that if we have a population of 300 million with 5%
infection, then we need about 27 million unbiased tests per day for 90% confidence that we have found 90% of the cases. For
COVID-19, it remains very unlikely that case numbers reported represent an accurate estimate of the extent of disease spread.
Furthermore, these numbers cannot be compared from place to place or time to time because of changes in testing bias Lipton
et al. (2020). As an example of how testing bias can affect perception of a trend, we simulate of an artificial scenario where
testing capacity increases drastically part-way through the course of an infection in fig. 2, and demonstrate that considering
only the number of positive tests per day completely obscures a peak in the dynamics. On the other hand, simply considering
the proportion of tests in a day which are positive reveals the true dynamics. This emphasizes the importance of proportion of
positive tests over the number of positive tests.
Testing for COVID-19 is clearly biased toward finding infected individuals. While reduced testing has drawbacks for
addressing particular scenarios, such as screening healthcare workers, it also has important benefits for tracking the population
level trends that inform policy decisions. As an intuitive example, consider a population with a very small proportion of
COVID-19 cases, as would be expected in the very early or very late stages of an outbreak. Heavily biased testing helps better
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Figure 10. Correlation between positive test percentage and tests performed in each state. Significance indicates p< 0.05,
p< 0.01, p< 0.001, and p< 0.0001.
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detect the infection by focusing on where the cases are rather than spending the vast majority of tests on negative results. In
this sense, biased testing is a form of importance sampling. Furthermore, biased testing reduces the number of tests needed
to identify all or most infected individuals. In fig. 1, we show the number of samples needed for bias parameters ranging
from B= 1 to B= 50. Bias in testing is the natural result of the role of testing in the healthcare setting, and this confirms the
advantages bias has for detecting population trends. However, using bias in testing as shown in eqs. (6) to (8), we see in fig. 4
that the spread of the infection will be overestimated significantly by biased testing. In other words, to accurately estimate the
spread of disease, we must estimate the bias parameter B. This can be done by conducting a separate set of unbiased tests and
using the relationship given by eq. (13). If we assume that the testing bias is constant (which is reasonable for a single day), this
is a Monte-Carlo estimator where the error in this estimation is determined by the variance in the estimate. We simulated with a
bias B= 10, and show the variance of single-day estimates for B with various biased and unbiased testing capacities in fig. 3.
From that simulation, we conclude that it is not unreasonable to estimate bias with 1000 unbiased samples per day, in addition
to a larger capacity of biased testing.
Policy changes during an outbreak, such as those seen during the COVID-19 outbreak with changes in stay-at-home orders,
appear to be based on trends in the disease dynamics, i.e., whether disease spread is accelerating or decelerating, or if there
have been changes to the rate of acceleration. Our work shows that we can account for how bias in the testing changes in
determining the trend. Moreover, we show that the overall positive or negative trend is not overly sensitive to the bias, meaning
that assuming an approximately constant bias may work for most estimates. It is important to note that determining the sign of
trends in the disease is easier when the trends are larger in magnitude, as shown in fig. 5. The less change there is in infection
rate, such as those through smaller policy changes, the more testing is needed to identify an effect. As an example, we see in
fig. 6 that 8100 samples per day is enough to give good confidence in the estimated sign of a 5-day trend in disease dynamics
for most of the course of an outbreak. This confidence is low when the trend is very weak, meaning the true dynamics are at a
local maximum (peak) or minimum (valley). Finally, we see in fig. 7 that a constant bias in testing actually improves our ability
to detect the sign of a trend in the dynamics. This is because biased testing magnifies trends in the data, as can be seen in fig. 4.
We see again that 8100 tests per day gives high confidence in the sign of five day trends in the data as long as that data is done
with a constant high bias.
Policy may also be based on other metrics in sampling data, such as the occurrence of peaks or more complicated model
fitting. Our model of sampling provides a method for testing the confidence of these metrics. As an example we show that the
exact peaks in an outbreak can be found, as seen in table 2, but there will likely be a large number of false peaks, as seen in
table 1. However, with the right smoothing, critical points in the dynamics can be identified with some confidence, as shown in
fig. 8.
Finally, as a relevant test of our approach and an exploration of real data from COVID-19, we use data from the COVID
Tracking ProjectLipton et al. (2020) for the state of Minnesota to compute 5-day trends for that data, shown in fig. 9. For data
collected after mid April, 2020, testing capacity was generally over 2000 samples per day, and so these estimates can be seen as
somewhat reliable with bias assumed to be approximately constant.
We also show the correlation between positive test percentage and number of tests performed for each state in fig. 10. We
see that in Minnesota there is no significant correlation; we assume that bias has been relatively constant. This was, however,
an uncommon situation. In most states, there is a significant anti-correlation between between positive test percentage and
number of tests performed. This may be due to changes in the policies of healthcare providers and government organizations
as tests become available. We must therefore account for this change in bias when discussing trends in the spread of the
disease. Additionally, some of this correlation may be due to the occurrence of days on which negative tests are not reported or
under-reported. We may model changes in bias simply by choosing some time-dependent bias functions B(t) in eqs. (6) to (8).
We provide a model of sampling in a disease outbreak in order to simulate data analysis in different outbreak situations, and
to assess infection testing strategies. Clearly, we should account for the confidence we have in the measurements of metrics used
to set policy. This confidence is affected by testing capacity, errors, and bias. Our model provides a method to assess confidence
with time-varying testing capacity and bias by simulating sampling over the course of an epidemic. This model demonstrates
the importance of tracking testing capacity, estimating possible changes in bias, and tracking positive test percentage rather
than raw number of positive tests. Our model provides an essential tool in designing an effective response to the outbreak of an
infectious disease.
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CODE AVAILABILITY
Our code to generate sample paths of the model is written in the language go, and compiled as the executable file disease_confidence.
Code to perform Monte-Carlo simulation is available as python scripts. All code is available at https://github.com/jdbrunner/disease_net.
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A MODELS USED TO GENERATE DYNAMICS
SIR model
We generate SIR dynamics with the ODE model
dxS
dt
=−βxIxS
dxI
dt
= βxIxS− γxi
dxR
dt
= γxI
where xS,xI ,xR represent the proportion of the population that is susceptible, infected, or recovered from the disease, respectively.
We allow β = β (t) to be a function of time, and in the above simulations take
β (t) =
1
15
(
2− exp
(
−
(
t−50
15
)2))
(14)
and γ = 115 . This dynamic parameterization allows us to generate an infection with more than one peak time, as can be seen in
fig. 4.
Using these dynamics, we take I1(t) = xI(t), I2(t) = 0, and H(t) = xS(t)+ xR(t).
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SAIR model
We also test dynamics which include an asymptomatic but infected population. We generate these dynamics with the model
dxS
dt
=−(β11+β12)xI1xS− (β21+β22)xI2xS
dxI1
dt
= β11xI1xS+β21xI2xS− γxI1 −δxI1
dxI2
dt
= β12xI1xS+β22xI2xS− γxI2 +δxI1
dxR
dt
= γ(xI1 + xI2)
where xS,xI1 ,xI2 ,xR represent the proportion of the population that is susceptible, asymptomatic infected, symptomatic infected,
or recovered from the disease, respectively.
Using these dynamics, we have I1(t) = xI1(t), I
2(t) = xI2(t), and H(t) = xS(t)+ xR(t).
B ACCOUNTING FOR SMALL POPULATIONS.
The model as described above assumes that members of the population may be re-tested immediately after being tested. This is
reflected in the fact that performing a test has no effect on eqs. (9) and (10). In large populations, this assumption is reasonable
because the proportion of the population who have been tested is not significant. On the other hand, in small populations we
must model the limited availability of untested members of the population.
To account for this effect, we must estimate the proportion of each sub-population (I1(t), I2(t),H(t)) which is available
for testing. We assume that testing removes one person from testable population, and those removed are re-introduced after
some exponential wait time. However, we still must approximate how the overall disease dynamics change the tested and
untested population. That is, we must account for a healthy individual who has been tested becoming infected before being
re-introduced into the testable population, or an infected individual recovering.
We make the following simplifying assumption:
dxT
dt
=
xT
x
dx
dt
(15)
where x= I1, x= I2, or X =H represent total sub-populations and xT is the number of tested and not-yet reintroduced members
of the sub-population. In practice, we use an Euler approximation to estimate the proportion of a sub-population ineligible for
testing:
xT (t2) = xT (t1)+
xT (t1)
x(t1)
(x(t2)− x(t1)) = xT (t1)x(t1) x(t2). (16)
where t1, t2 are the times of consecutive stochastic events in the model (i.e. a test performed or population member re-introduced
into the testable population).
With this model, overestimation of the positive percentage due to biased testing lessens as the rate of testing increases, as
shown in fig. 11. This is due to the limited number of testable infected individuals at any time.
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Figure 11. Apparent bias decreases as the sampling rate increases in a limited population. Simulations were done with a
population size of 10000.
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